www.senology.org   -   Newsletter

"Join  the international senologic and oncologic  scientific community"

Gian Paolo Andreoletti, MD, Editor-in-Chief  -  paolo.andreoletti@senology.it

  Subscribe      Unsubscribe     Contact      Back Issues      www.senology.org / www.senology.it  Home Page

Literature Selection

Editorial

  • "Removing 5 sentinel lymph nodes is enough for accurate lymph node staging in the vast majority of breast cancers" - Kelly K. Hunt, Surgical Breast Section, Department of Surgical Oncology, M. D. Anderson Cancer Center, Houston, TX, USA
     
    "Our study determines how many sentinel lymph nodes (SLNs) need to be removed for accurate lymph node staging and which patient and tumor characteristics influence this number. Data from 777 patients with at least 1 SLN that was positive for cancer have been collected in this retrospective study. The mean number of SLNs removed in the 777 lymph node-positive patients was 2.9 (range, 1-13 SLNs). Greater than 99% of positive SLNs were identified in the first 5 lymph nodes removed. On multivariate analysis, mixed ductal and lobular histology, Caucasian race, inner quadrant tumor location, and T1 tumor classification significantly increased the number of SLNs that needed to be removed to achieve 99% recovery of all positive SLNs. In general, the removal of a maximum of 5 SLNs at surgery allowed for the recovery of >99% of positive SLNs in patients with breast cancer. Tumor histology, patient race, and tumor size and location may influence this number"
    (Comment on paper: 
    Yi M et al.: "How many sentinel lymph nodes are enough during sentinel lymph node dissection for breast cancer?", Cancer. 2008 [Epub ahead of print])

Press Releases

Video and Lectures

Calendar of Events

Literature Selection

Press Releases

Clinical Guidelines


Literature Selection

Editorial

  • "Changed cytokine patterns in the breast milk during inflammatory breast diseases and their side effects for the newborn"  - Achim Wöckel, Department of Gynecology and Obstetrics, University Hospital Ulm, Ulm, Germany
     
    "Despite a surge of evidence on the benefits of breastfeeding for mothers and the newborns there is a lack of valid and empirical data on lactation-related inflammatory breast diseases, which are also the most common reason for early weaning. Additionally there is also only little research on collateral effects of these puerperal diseases. But inflammatory breast diseases during lactation, like milk stasis or puerperal mastitis, cause a modulation of cytokine levels in breast milk. This imbalance of cytokines in breast milk may have severe consequences for the newborn, which in turn affects the child's development. In our systematic review all important studies and possible health effects for the childs are summarized with regard to different cytokines. Until now proceeding of breastfeeding is recommended also during theses inflammatory breast diseases, but we have to consider these side effects for the newborn in the future and need further investigations to analyze the correlations"
    (Comment on paper: 
    Wockel A et al.: "Inflammatory breast diseases during lactation: health effects on the newborn-a literature review", Mediators Inflamm. 2008;2008:298760)

     

Happy Holidays!

 

Educational Grants - Sincere appreciation is extended to the following companies for their generous support of this activity:
-
Roche
-
AstraZeneca

If this e-mail has reached you in error, simply click on the following link and unsubscribe yourself Unsubscribe

Contact info - For advertising information please contact: A&B@senology.it . For other enquiries, problems or suggestions please contact: staff@senology.it

© A&B Edizioni Medico-Scientifiche - Milan,  Italy.  Fax: +39.035.7171000